Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-1-26
pubmed:abstractText
The effects of the antipsychotic clozapine on the function of the cloned alpha(7) subunit of the nicotinic acetylcholine (nACh) receptor expressed in Xenopus oocytes was investigated by using the two-electrode voltage-clamp technique. Clozapine reversibly inhibited nicotine (10 microM)-induced currents in a concentration-dependent manner (300 nM to 90 microM), with an IC(50) value of 3.2+/-0.4 microM. The effect of clozapine was not dependent on the membrane potential. Clozapine did not affect the activity of endogenous Ca(2+)-dependent Cl(-) channels since the inhibition by clozapine was unaltered by the intracellularly injected Ca(2+) chelator BAPTA and perfusion with Ca(2+)-free bathing solution containing 2mM Ba(2+). Clozapine decreased the maximal nicotine-induced responses without significantly affecting its potency, indicating that it acts as a noncompetitive antagonist on alpha(7)-nACh receptors. In hippocampal slices, the whole-cell recordings from CA1 pyramidal neurons indicated that the increases in the frequency and amplitudes of the GABA-mediated spontaneous inhibitory postsynaptic currents induced by bath application of 2 mM choline, a specific agonist for alpha(7)-nACh receptors, were abolished after 10 min application of 5 microM clozapine. In conclusion, these results demonstrate that clozapine inhibits the function of alpha(7)-nACh receptors expressed in Xenopus oocytes and in hippocampal neurons.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0028-3908
pubmed:author
pubmed:issnType
Print
pubmed:volume
52
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
387-94
pubmed:dateRevised
2010-6-4
pubmed:meshHeading
pubmed-meshheading:17161853-Animals, pubmed-meshheading:17161853-Animals, Newborn, pubmed-meshheading:17161853-Antipsychotic Agents, pubmed-meshheading:17161853-Choline, pubmed-meshheading:17161853-Clozapine, pubmed-meshheading:17161853-Dose-Response Relationship, Drug, pubmed-meshheading:17161853-Dose-Response Relationship, Radiation, pubmed-meshheading:17161853-Drug Interactions, pubmed-meshheading:17161853-Female, pubmed-meshheading:17161853-Hippocampus, pubmed-meshheading:17161853-Inhibitory Concentration 50, pubmed-meshheading:17161853-Male, pubmed-meshheading:17161853-Membrane Potentials, pubmed-meshheading:17161853-Microinjections, pubmed-meshheading:17161853-Nicotine, pubmed-meshheading:17161853-Nicotinic Agonists, pubmed-meshheading:17161853-Nootropic Agents, pubmed-meshheading:17161853-Oocytes, pubmed-meshheading:17161853-Patch-Clamp Techniques, pubmed-meshheading:17161853-Pyramidal Cells, pubmed-meshheading:17161853-Rats, pubmed-meshheading:17161853-Receptors, Nicotinic, pubmed-meshheading:17161853-Xenopus laevis
pubmed:year
2007
pubmed:articleTitle
Antipsychotic clozapine inhibits the function of alpha7-nicotinic acetylcholine receptors.
pubmed:affiliation
Laboratory of Molecular & Cellular Neurobiology, National Institute on Alcohol Abuse & Alcoholism, NIH/DHHS, 12501 Washington Avenue, Bethesda, MD 20892-8205, USA.
pubmed:publicationType
Journal Article, In Vitro, Research Support, N.I.H., Extramural